CP3’s Dr. Tom Radomski received a new VA Merit grant to lead EVOLV-Rx VA, a study aimed at reducing low-value prescribing in VA Community Living Centers. The project will use an EVOLV-Rx dashboard to...
Congratulations to CP3 Director Dr. Walid Gellad and the mPROVEN study team on a new award to create a playbook for ethical use of machine learning-based opioid risk prediction models, building on...
We are thrilled to announce a new R01 grant award for the study “Developing a ML algorithm to predict relapse in OUD treatment and building an evidence-based clinical decision support (CDS) e-tool...
A study led by former CP3 faculty affiliate Dr. Utibe Essien and co-authored by CP3 Director Dr. Walid Gellad was featured in Medscape. The team found that Black patients with AFib had a much higher...
CP3 Faculty Affiliate, Dr. Bryant Shuey, spoke with UPMC News about his study that showed in recent years, young women binge drank more often than their male counterparts. Read more about this work.
CP3 Associate Director Dr. Katie Suda and former CP3 postdoc Dr. Patience Moyo Dow were part of a National Academies of Sciences, Engineering, and Medicine committee that found that Veterans who were...
CP3 faculty affiliate, Pitt Nursing faculty, and clinician-scientist Dr. Sarah Belcher studies the variety of factors that affect adherence to oral anticancer medications. Learn more about Dr. Belcher...
CP3 medical student Noah Feder and faculty affiliate Dr. Jing Luo analyzed glucagon prescriptions over time, focusing on periods before and after 2018, when new glucagon products entered the market. R...
CP3 faculty affiliate Dr. Tim Anderson spoke with STAT about the PREVENT model, a simpler, less expensive way to predict risk of heart failure. “There have been prior risk estimation approaches for...
Many health and science folks have left Twitter/X for Bluesky recently. CP3 Director Dr. Walid Gellad spoke with Stat News about the change and how each platform affects communication.
